Jayne M. Ness
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jayne M. Ness has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Amy Tara Waldman
Division of Neurology, Children's Hospital of Philadelphia, PA
1 shared publication - Anita L. Belman
Department of Neurology, Stony Brook University, Stony Brook, New York; NYU Langone Multiple Sclerosis Comprehensive Care Center, New York, New York;
1 shared publication - Anna L. Travelstead
Flow Cytometry Facility, Southern Illinois University School of Medicine, Springfield, IL 62794-9626, USA
1 shared publication - Benjamin M. Greenberg
Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX, USA
1 shared publication - Bianca Weinstock-Guttman
Department of Neurology, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University of Buffalo Jacobs School of Medicine
1 shared publication - Elizabeth D. Tate
National Pediatric Myoclonus Center, National Pediatric Neuroinflammation Organization, Inc, Orlando, Florida
1 shared publication
Latest Publications
- Open Access
- 1 September 2021
- Published by Wolters Kluwer Health in Neurology Neuroimmunology & Neuroinflammation
- Vol. 8 (5)
Familial History of Autoimmune Disorders Among Patients With Pediatric Multiple Sclerosis
Background and Objective The objective of this study was to determine whether family members of patients with pediatric multiple sclerosis (MS) have an increased prevalence of autoimmune conditions compared with controls. Methods Data collected during a pediatric MS case-control study of risk factors included information about various autoimmune diseases in family members. The frequency of these disorders was compared between cases and controls. Results There was an increased rate of autoimmune diseases among family members of pediatric MS cases compared with controls with first-degree history of MS excluded (OR = 2.27, 95% CI 1.71–3.01, p < 0.001). There was an increased rate of MS among second-degree relatives of pediatric MS cases compared with controls (OR = 3.47, 95% CI 1.36–8.86, p = 0.009). The OR for MS was 2.64 when restricted to maternal relatives and 6.37 when restricted to paternal relatives. Discussion The increased rates of autoimmune disorders, including thyroid disorders and MS among families of patients with pediatric MS, suggest shared genetic factors among families with children diagnosed with pediatric MS.
- 1 September 2021
- Published by Wolters Kluwer Health in Neurology Neuroimmunology & Neuroinflammation
- Vol. 8 (5)
Open AccessFamilial History of Autoimmune Disorders Among Patients With Pediatric Multiple Sclerosis
Background and Objective The objective of this study was to determine whether family members of patients with pediatric multiple sclerosis (MS) have an increased prevalence of autoimmune conditions compared with controls. Methods Data collected during a pediatric MS case-control study of risk factors included information about various autoimmune diseases in family members. The frequency of these disorders was compared between cases and controls. Results There was an increased rate of autoimmune diseases among family members of pediatric MS cases compared with controls with first-degree history of MS excluded (OR = 2.27, 95% CI 1.71–3.01, p < 0.001). There was an increased rate of MS among second-degree relatives of pediatric MS cases compared with controls (OR = 3.47, 95% CI 1.36–8.86, p = 0.009). The OR for MS was 2.64 when restricted to maternal relatives and 6.37 when restricted to paternal relatives. Discussion The increased rates of autoimmune disorders, including thyroid disorders and MS among families of patients with pediatric MS, suggest shared genetic factors among families with children diagnosed with pediatric MS.
- Open Access
- 16 January 2013
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 10 (1) , 10
BAFF/APRIL system in pediatric OMS: relation to severity, neuroinflammation, and immunotherapy
B-cell dysregulation has been implicated but not fully characterized in pediatric opsoclonus-myoclonus syndrome (OMS), a neuroblastoma-associated neuroinflammatory disorder.
- 16 January 2013
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 10 (1) , 10
Open AccessBAFF/APRIL system in pediatric OMS: relation to severity, neuroinflammation, and immunotherapy
B-cell dysregulation has been implicated but not fully characterized in pediatric opsoclonus-myoclonus syndrome (OMS), a neuroblastoma-associated neuroinflammatory disorder.